Cell-sheet regenerative medicine “Regenerative Medicine” for customized medical care -the challenge we aim to fullfill. Regenerative medicine plays an important role for customized medical care that is increasingly popular. Regenerative medicine exploits the therapeutic value of the body's own stem cells and growth factors to repair cells, tissues, and organs. Of increasing therapeutic interest, small quantities of a patients' own stem or progenitor cells are collected by biopsy and cultured in a special cell culturing dish. When cells grow to confluence, the living cell-sheet is collected by enzyme-free and transplanted back into the patient again. Focusing on regenerative medicine as our core business, we provide key cutting edge technology and solutions as well as tissue-engineered products such as corneas and skin.
Looking for a particular CellSeed Inc. employee's phone or email?
The CellSeed Inc. annual revenue was $9 million in 2026.
Kazunobu Asano is the Director, Intelligent Cell Cultureware Business Division of CellSeed Inc..
1 people are employed at CellSeed Inc..
CellSeed Inc. is based in Tokyo, Tokyo.
The NAICS codes for CellSeed Inc. are [5417, 54, 541713, 54171, 541].
The SIC codes for CellSeed Inc. are [873, 87].